UNSPSC 51283207: Sedecamycin

This classification denotes a macrolide antibiotic with the molecular formula C27H35NO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WLK252Z51F, chemically known as pyruvamide, n-(7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-, 13-acetate, (all-e)-(1s,2r,7s,13s,15r,19r)-(-)- but generally known as sedecamycin, which bears US NIH Compound Identifier 5382567.

UNSPSC 51283207 Sedecamycin (Commodity) does not align with recent state and local procurement activity posted under this code. The most recent opportunities tagged to 51283207 involve naloxone and safe drug deactivation systems, direct-to-manufacturer pharmaceutical prescriptions, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products — none of which are sedecamycin or antibiotics in that class. The source shows no solicitations for sedecamycin itself. State and local governments buying under this code designation are primarily counties and cities (Seminole County, Florida; Tampa, Florida) and state health agencies (Texas Health and Human Services Commission; Minnesota Department of Administration), but the actual procurement scope reflects emergency medical supplies, pharmacy benefit programs, and pharmaceutical supply chain contracting rather than the antibiotic category the code nominally represents.

Recent activity spans Florida, Texas, and Minnesota, with issuing bodies ranging from county public health departments to state cooperative purchasing alliances. Representative recent opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response date; the City of Tampa's bid 26-P-00145 (posted March 25, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities. The code shows a substantial mismatch between its nominal pharmaceutical classification and the actual work being procured under it in the recent state and local market.